Investors knew ahead of the Nov. 6 arrival of Puma Biotechnology's (PBYI +0.22%) third-quarter update that the report was going to be an important one. The question on everyone's mind was pretty ...

Vir Biotechnology has seen sharp swings over the past few years, which puts fresh focus on a simple question for anyone ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...